Bumrungrad Hospital Public Company Limited
BUHPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7 | $6 | $6 | $6 |
| % Growth | 8.1% | -1.9% | -5.1% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 53% | 52.5% | 50.5% | 49.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | -$0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $2 | $2 | $2 | $2 |
| % Margin | 37.8% | 37.8% | 33.9% | 32.8% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $3 | $2 | $2 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2 | $2 | $2 | $2 |
| % Margin | 31.2% | 30.8% | 28.2% | 29.4% |
| EPS | 2.56 | 2.34 | 2.18 | 2.2 |
| % Growth | 9.4% | 7.3% | -0.9% | – |
| EPS Diluted | 2.35 | 2.14 | 2 | 2.19 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $3 | $3 | $2 | $2 |
| % Margin | 42.7% | 43% | 39.1% | 38.1% |